山东大学耳鼻喉眼学报 ›› 2020, Vol. 34 ›› Issue (6): 42-48.doi: 10.6040/j.issn.1673-3770.0.2020.094

• • 上一篇    

内镜经翼突入路切除中颅底恶性肿瘤30例临床分析

郑朝攀1,曾小燕1,张博1,韩灵1,罗曼2,马玲国1   

  1. 1. 深圳市人民医院 耳鼻咽喉科, 广东 深圳 518020;
    2. 深圳市保健委员会办公室, 广东 深圳 518000
  • 发布日期:2021-01-11
  • 通讯作者: 马玲国. E-mail: ljymax@163.com
  • 基金资助:
    深圳市科技创新委员会基础研究项目(JCYJ20190907150811212)

Clinical analysis of the endonasal transpterygoid approach to the resection of malignant tumors involving the middle skull base of 30 cases

ZHENG Chaopan1, ZENG Xiaoyan1, ZHANG Bo1, HAN Lin1, LUO Man2, MA Lingguo1   

  1. 1. Department of Otolaryngology, Shenzhen People Hospital, Shenzhen 518020, Guangdong, China;
    2. Shenzhen Healthcare Committee Office, Shenzhen 518000, Guangdong, China
  • Published:2021-01-11

摘要: 目的 探讨内镜经翼突入路切除中颅底恶性肿瘤的疗效。 方法 回顾分析30例经鼻内镜翼突入路切除累及中颅底恶性肿瘤患者相关资料,总结该手术相关技巧和经验,用Kaplan-Meier法进行生存分析,探讨肿瘤累及颈内动脉对预后影响。 结果 手术均为全身麻醉下进行。平均手术时间145 min,平均术中出血470 mL,术中脑脊液漏6例;术后颅内感染2例、脑脊液漏1例,均痊愈。病理分别为复发性鼻咽癌21例、腺样囊性癌3例、黏液表皮样癌2例、脊索瘤1例、癌肉瘤1例、鼻咽滤泡树突状细胞肉瘤1例和颅底淋巴上皮瘤样癌1例。30例颅底恶性肿瘤患者术后1年、2年、3年、5年生存率分别为92.9%、79.6%、48.6%和36.5%;复发性鼻咽癌中位生存期为29.00[35.00,23.00]个月,其他恶性肿瘤38.00[38.00,38.00]个月,生存曲线之间差异有统计学意义(χ2=4.248; P=0.039);颈内动脉累及和未累及患者中位数分别为16.00[23.00,14.00]个月和36.00[80.00,31.00] 个月,生存曲线差异有统计学意义(χ2=9.421; P=0.002);而且颈内动脉受累是影响患者预后的危险因素,颈内动脉受累及患者的死亡风险是未受累患者的9.678倍(HR=9.678,P=0.011)结论 内镜翼突入路是部分中颅底恶性肿瘤外科治疗的合理方案,颈内动脉累及侵犯是影响疾病预后的危险因素。

关键词: 中颅底, 恶性肿瘤, 内镜, 翼突入路, 颈内动脉

Abstract: Objective To explore the endonasal transpterygoid approach to the resection of malignant tumors involving the middle skull base and its outcomes. Methods The surgery-related data of 30 cases of malignant tumors involving the middle skull base attended to at the Department of Otorhinolaryngology of the Shenzhen People's Hospital between October 2012 and June 2019 were retrospectively analyzed. The skills and experience of the surgeons and the techniques employed during the surgery were summarized. The Kaplan-Meier method was used for survival analysis. The prognoses of the tumor-involved internal carotid arteries were also explored. Results The surgeries, using the endonasal transpterygoid approach, were performed under general anesthesia; the average duration of surgery was 145 minutes, the average intraoperative blood loss was 470 mL, and intraoperative cerebrospinal fluid leakage occurred in 6 cases. The postoperative intracranial infection in 2 cases and the cerebrospinal fluid leakage in 1 case were cured. Pathologically, there were 21 cases of recurrent nasopharyngeal carcinoma, 3 cases of adenoid cystic carcinoma, 2 cases of mucoepidermoid carcinoma, 1 case of chordoma, 1 case of carcinosarcoma, 1 case of nasopharyngeal follicular dendritic cell sarcoma, and 1 case of skull base lymphocytic epithelioma-like carcinoma. The 1-year, 2-year, 3-year, and 5-year survival rates of the 30 patients with malignant tumors were 92.9%, 79.6%, 48.6%, and 36.5%, respectively. The median survival duration was 29.00(35.00, 23.00)months for recurrent nasopharyngeal carcinoma and 38.00(38.00, 38.00)months for other malignant tumors. The survival curves of recurrent nasopharyngeal carcinomas and other malignant tumors showed statistical significance(χ2=4.248; P=0.039). The median durations of survival of patients with and without internal carotid artery invasion were 16.00(23.00, 14.00)and 36.00(80.00, 31.00)months, respectively, and their survival curves were significantly different(χ2=9.421; P=0.002). Internal carotid artery involvement is a risk factor for poor prognosis, and the risk of death of patients with internal carotid artery involvement was 9.678 times that of those without involvement(HR=9.678, P=0.011). Conclusion The endoscopic transpterygoid approach is a reasonable option for the surgical treatment of tumors involving the middle skull base; however, the involvement of the internal carotid artery is an important prognostic factor that should always be considered.

Key words: Middle skull base, Malignant tumor, Endoscope, Transpterygoid approach, Internal carotid artery

中图分类号: 

  • R765.9
[1] Jho HD, Carrau RL. Endoscopic endonasal transsphenoidal surgery: experience with 50 patients[J]. J Neurosurg, 1997, 87(1): 44-51. doi:10.3171/jns.1997.87.1.0044.
[2] Cappabianca P, Alfieri A, de Divitiis E. Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery(FEPS)[J]. Minim Invasive Neurosurg, 1998, 41(2): 66-73. doi:10.1055/s-2008-1052019.
[3] Kassam AB, Gardner P, Snyderman C, et al. Expanded endonasal approach: fully endoscopic, completely transnasal approach to the middle third of the clivus, petrous bone, middle cranial fossa, and infratemporal Fossa[J]. Neurosurg Focus, 2005, 19(1): E6.
[4] Kassam AB, Prevedello DM, Carrau RL, et al. The front door to meckel's cave: an anteromedial corridor via expanded endoscopic endonasal approach-technical considerations and clinical series[J].Neurosurgery,2009,64(3):71-82. doi:10.1227/01.neu.0000335162.36862.54.
[5] Belykh E, Yagmurlu K, Lei T, et al. Quantitative anatomical comparison of the ipsilateral and contralateral interhemispheric transcallosal approaches to the lateral ventricle[J]. J Neurosurg, 2018, 128(5): 1492-1502. doi:10.3171/2017.1.JNS161338.
[6] 刘剑锋, 韩军, 杨大章, 等. 内镜经翼突入路的解剖及其在处理颅底病变中的应用[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(11): 909-914. doi:10.3760/cma.j.issn.1673-0860.2015.11.006. LIU Jianfeng, HAN Jun, YANG Dazhang, et al. Surgical anatomy, technique and application of endoscopic endonasal transpterygoid approach in skull base surgery[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2015, 50(11): 909-914. doi:10.3760/cma.j.issn.1673-0860.2015.11.006.
[7] 郑朝攀, 周敬淳, 韩灵, 等. 内镜翼突入路治疗中颅底良性占位性病变[J]. 山东大学耳鼻喉眼学报, 2015, 29(4): 51-54. ZHENG Chaopan, ZHOU Jingchun, HAN Ling, et al. The management of benign space-occupying lesion of the middle skull base via the endoscopic pterygopalatine space approaches[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2015, 29(4): 51-54.
[8] Doescher J, Veit JA, Hoffmann TK. The 8th edition of the AJCC Cancer Staging Manual: Updates in otorhinolaryngology, head and neck surgery[J]. HNO, 2017, 65(12): 956-961. doi:10.1007/s00106-017-0391-3.
[9] Truong HQ, Sun XC, Celtikci E, et al. Endoscopic anterior transmaxillary “transalisphenoid” approach to Meckel's cave and the middle cranial fossa: an anatomical study and clinical application[J]. J Neurosurg, 2018, 130(1): 227-237. doi:10.3171/2017.8.JNS171308.
[10] Mehta GU, Raza SM. Endoscopic endonasal transpterygoid approach to petrous pathologies: technique, limitations and alternative approaches[J]. J Neurosurg Sci, 2018, 62(3): 339-346. doi:10.23736/S0390-5616.18.04302-3.
[11] Amit M, Abergel A, Fliss DM, et al. The clinical importance of quality-of-life scores in patients with skull base tumors: a meta-analysis and review of the literature[J]. Curr Oncol Rep, 2012, 14(2): 175-181. doi:10.1007/s11912-012-0222-3.
[12] Vlantis AC, Chan HS, Tong MC, et al. Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma: a multivariate analysis of prognostic factors[J]. Head Neck, 2011, 33(8): 1126-1131. doi:10.1002/hed.21585.
[13] Na'ara S, Amit M, Billan S, et al. Outcome of patients undergoing salvage surgery for recurrent nasopharyngeal carcinoma: a meta-analysis[J]. Ann Surg Oncol, 2014, 21(9): 3056-3062. doi:10.1245/s10434-014-3683-9.
[14] Chen MY, Wen WP, Guo X, et al. Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma[J]. Laryngoscope, 2009, 119(3): 516-522. doi:10.1002/lary.20133.
[15] Chan JYW, Wong STS, Wei WI. Surgical salvage of recurrent T3 nasopharyngeal carcinoma: Prognostic significance of clivus, maxillary, temporal and sphenoid bone invasion[J]. Oral Oncol, 2019, 91: 85-91. doi:10.1016/j.oraloncology.2019.02.023.
[16] Chen MM, Roman SA, Sosa JA, et al. Predictors of survival in sinonasal adenocarcinoma[J]. J Neurol Surg Part B Skull Base, 2015, 76(3): 208-213. doi:10.1055/s-0034-1543995.
[17] Cipriani NA, Lusardi JJ, McElherne J, et al. Mucoepidermoid carcinoma: a comparison of histologic grading systems and relationship to MAML2 rearrangement and prognosis[J]. Am J Surg Pathol, 2019, 43(7): 885-897. doi:10.1097/PAS.0000000000001252.
[18] Bakker SH, Jacobs WCH, Pondaag W, et al. Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival[J]. Eur Spine J, 2018, 27(12): 3043-3058. doi:10.1007/s00586-018-5764-0.
[19] Misra P, Husain Q, Svider PF, et al. Management of sinonasal teratocarcinosarcoma: a systematic review[J]. Am J Otolaryngol, 2014, 35(1): 5-11. doi:10.1016/j.amjoto.2013.04.010.
[20] Pang J, Mydlarz WK, Gooi Z, et al. Follicular dendritic cell sarcoma of the head and neck: Case report, literature review, and pooled analysis of 97 cases[J]. Head Neck, 2016, 38(Suppl 1): E2241-E2249. doi:10.1002/hed.24115.
[21] 刘全, 孙希才, 于华鹏, 等. 鼻内镜下鼻咽癌切除术的手术分型[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 39-45. doi:10.6040/j.issn.1673-3770.1.2019.016. LIU Quan, SUN Xicai, YU Huapeng, et al. Types of endoscopic transnasal nasopharyngectomy for nasopharyngeal carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 39-45. doi:10.6040/j.issn.1673-3770.1.2019.016.
[1] 陈坤,李磊,孟国珍,杨军,侯东明. 婴儿鼻腔软骨间叶性错构瘤2例及文献复习[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 27-30.
[2] 王磊,袁英,于学民,韩玉娥,王宁,李晓,李龙,侯妮妮. 鼻内镜手术治疗上颌骨囊肿的临床分析[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 31-35.
[3] 谷少尉,侯元友,魏东敏,李文明,陈东彦,徐晨阳,雷大鹏,潘新良. 声门上喉癌舌瓣修补术后吞咽功能恢复[J]. 山东大学耳鼻喉眼学报, 2020, 34(5): 127-131.
[4] 翟性友,侯俊胜,李新建,王新,解营利,王文佳. 鼻腔鼻窦结石临床诊治体会[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 92-96.
[5] 青晓艳, 徐义全综述李超审校. 甲状腺未分化癌的分子机制研究[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 26-31.
[6] 梁慧敏,汪李琴,万文锦,施赛磊,袁静,沈宇杰,张佳程,毛泽凡,倪璟滋,潘奕文,陈智斌,程雷. 耳鼻咽喉科内镜室新型冠状病毒感染防控方案的探讨与实践[J]. 山东大学耳鼻喉眼学报, 2020, 34(2): 88-92.
[7] 王暄琪. 可植入式眼内镜术后拱高及相关因素[J]. 山东大学耳鼻喉眼学报, 2020, 34(2): 72-78.
[8] 谢书华, 杨竹梅, 刘慧茹, 董晶. NLR、LMR、PLR预测慢性鼻窦炎鼻内镜术后复发价值[J]. 山东大学耳鼻喉眼学报, 2020, 34(1): 54-57.
[9] 王海英. 鼻内镜下二线减张鼻中隔矫正术43例临床分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 166-168.
[10] 陈国辉,和守睆,孙青,高天乐,白广平. 鼻内镜术中不同中鼻甲处理方式治疗慢性鼻-鼻窦炎伴鼻息肉效果比较[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 82-86.
[11] 李强,刘志元,周涵. 鼻内镜下蝶腭动脉阻断术治疗老年难治性鼻出血[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 92-95.
[12] 鞠丽娴,李井成,夏克玉,董伟达. 鼻内镜下联合自制角度喉钳切除声门暴露困难声带息肉23[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 116-118.
[13] 王登元, 陈智斌, 邢光前. 耳内镜微创术——耳科手术的新途径[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 27-30.
[14] 姜彦. 鼻咽癌复发及鼻内镜外科手术的应用[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 1-11.
[15] 邱前辉,陈卓. 鼻内镜手术治疗首诊局部晚期鼻咽癌及放疗后严重并发症的作用[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 17-20.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!